Grants and Contributions:
Title:
Treadwell Canada: COVID-19 Vaccine Alliance Module 1 of 3.
Agreement Number:
969432
Agreement Value:
$2,495,528.00
Agreement Date:
Aug 21, 2020 - Jan 31, 2022
Description:
Leveraging the TCRyption Platform, Treadwell and TIO management, this project employs the scientific and technical expertise at UHN, UBC, and BCCDC. This collaborative project engages multiple academic groups across Canada to develop and evaluate 3 different vaccine products with unparalleled durability. Enmeshing scientific expertise in various fields with the TCRyption technology, our vaccine products aim to provide durable protection against COVID-19 for the Canadian public.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Toronto, Ontario, CA M5G 2M9
Reference Number:
172-2020-2021-Q4-969432
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
764731519
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 94 days.
Amendment Date
Oct 25, 2021
Recipient's Legal Name:
Treadwell Therapeutics Canada Inc.
Federal Riding Name:
University--Rosedale
Federal Riding Number:
35110
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: